Form 8-K - Current report:
SEC Accession No. 0001104659-25-005659
Filing Date
2025-01-23
Accepted
2025-01-23 16:50:22
Documents
15
Period of Report
2025-01-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm254181d1_8k.htm   iXBRL 8-K 27006
2 EXHIBIT 99.1 tm254181d1_ex99-1.htm EX-99.1 6176
6 GRAPHIC image_001.jpg GRAPHIC 3729
  Complete submission text file 0001104659-25-005659.txt   214704

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20250121.xsd EX-101.SCH 3003
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20250121_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20250121_pre.xml EX-101.PRE 22351
17 EXTRACTED XBRL INSTANCE DOCUMENT tm254181d1_8k_htm.xml XML 3751
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 25550737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)